Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Wirth

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2006
Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05)Daniel E Roos, Andrew Wirth, Bryan H Burmeister, et al.
British Journal of Haematology|April 4, 2023
Are dynamic or fixed FDG-PET measures of disease of greater prognostic value in patients with relapsed/refractory diffuse large B-cell lymphoma undergoing autologous haematopoietic stem cell transplantation?Belinda A Campbell, Rachel Brown, Alessandro Lambertini, et al.
International Journal of Radiation Oncology, Biology, Physics|March 11, 2020
Abscopal Regressions of Lymphoma After Involved-Site Radiation Therapy Confirmed by Positron Emission TomographyMichael P MacManus, Michael S Hofman, Rodney J Hicks, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 6, 2011
A randomized phase II trial of two regimens of moderate dose chemoradiation therapy for patients with non-small cell lung cancer not suitable for curative therapy: Trans Tasman Radiation Oncology Study TROG 03.07Bryan H Burmeister, Michael Michael, Elizabeth Burmeister, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2018
A Prospective, Multicenter Study of Involved-Field Radiation Therapy With Autologous Stem Cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma (ALLG HDNHL04/TROG 03.03)Andrew Wirth, H Miles Prince, Daniel Roos, et al.
Blood|April 11, 2020
ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemicJoachim Yahalom, Bouthaina Shbib Dabaja, Umberto Ricardi, et al.
The American Journal of Medicine|March 15, 2002
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphomaAndrew Wirth, John F Seymour, Rodney J Hicks, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2014
Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology GroupTim Illidge, Lena Specht, Joachim Yahalom, et al.
Leukemia & Lymphoma|April 25, 2007
Early therapeutic response assessment by (18)FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: isolated residual positivity involving bone is not usually a predictor of subsequent treatment failureAshley P Ng, Andrew Wirth, John F Seymour, et al.
Cancers|April 23, 2020
Durable Complete Remission and Long-Term Survival in FDG-PET Staged Patients with Stage III Follicular Lymphoma, Treated with Wide-Field Radiation TherapyMichael P MacManus, Rodney J Hicks, Mathias Bressel, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2006
Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05)Daniel E Roos, Andrew Wirth, Bryan H Burmeister, et al.
British Journal of Haematology|April 4, 2023
Are dynamic or fixed FDG-PET measures of disease of greater prognostic value in patients with relapsed/refractory diffuse large B-cell lymphoma undergoing autologous haematopoietic stem cell transplantation?Belinda A Campbell, Rachel Brown, Alessandro Lambertini, et al.
International Journal of Radiation Oncology, Biology, Physics|March 11, 2020
Abscopal Regressions of Lymphoma After Involved-Site Radiation Therapy Confirmed by Positron Emission TomographyMichael P MacManus, Michael S Hofman, Rodney J Hicks, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 6, 2011
A randomized phase II trial of two regimens of moderate dose chemoradiation therapy for patients with non-small cell lung cancer not suitable for curative therapy: Trans Tasman Radiation Oncology Study TROG 03.07Bryan H Burmeister, Michael Michael, Elizabeth Burmeister, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2018
A Prospective, Multicenter Study of Involved-Field Radiation Therapy With Autologous Stem Cell Transplantation for Patients With Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma (ALLG HDNHL04/TROG 03.03)Andrew Wirth, H Miles Prince, Daniel Roos, et al.
Blood|April 11, 2020
ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemicJoachim Yahalom, Bouthaina Shbib Dabaja, Umberto Ricardi, et al.
The American Journal of Medicine|March 15, 2002
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphomaAndrew Wirth, John F Seymour, Rodney J Hicks, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2014
Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology GroupTim Illidge, Lena Specht, Joachim Yahalom, et al.
Leukemia & Lymphoma|April 25, 2007
Early therapeutic response assessment by (18)FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: isolated residual positivity involving bone is not usually a predictor of subsequent treatment failureAshley P Ng, Andrew Wirth, John F Seymour, et al.
Cancers|April 23, 2020
Durable Complete Remission and Long-Term Survival in FDG-PET Staged Patients with Stage III Follicular Lymphoma, Treated with Wide-Field Radiation TherapyMichael P MacManus, Rodney J Hicks, Mathias Bressel, et al.
Pageof 8